In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...
Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices. The pharmaceutical industry, known for its rigorous research, complex ...
Deloitte attributed rising R&D costs to increases in trial times, complex research areas, economic factors, tech advancements and high attrition rates. (iStock / Getty Images Plus) The average cost ...
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...
SHANGHAI, June 18 (Reuters) - Drug research and development firms in China including WuXi AppTec (603259.SS), opens new tab and WuXi Biologics (2269.HK), opens new tab are changing project plans, ...
Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results